Stereoselective serum protein binding of mexiletine enantiomers in man. 1987

K M McErlane, and L Igwemezie, and C R Kerr

The binding of mexiletine enantiomers to human serum proteins was studied in vitro using serum samples collected from five healthy male subjects. Racemic mexiletine was added to an aliquot of each subject's serum to cover the concentration range 0.2 to 2.0 micrograms/mL. Following ultrafiltration of the serum samples containing racemic mexiletine, the individual enantiomers were determined using a stereoselective high-performance liquid chromatographic method developed in our laboratory. The assay data thus obtained for the free levels of the enantiomers showed that the free fraction of S(+) mexiletine was 28.32 +/- 1.45% and that of the R(-) enantiomer was 19.80 +/- 1.49%. The binding was shown to be significantly greater (p less than 0.001) for R(-) mexiletine than its antipode. There was no evidence of concentration dependence in binding over the concentration range studied, which covered the normal therapeutic range. However, significant inter-individual variability in the free fractions was observed. The total binding of the enantiomers was 76%.

UI MeSH Term Description Entries
D008297 Male Males
D008801 Mexiletine Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties. KO-1173,KO1173,KOE-1173,Mexiletene,Mexiletine Hydrochloride,Mexitil,Mexitil PL,Mexityl,Novo-Mexiletine,KO 1173,KOE 1173,KOE1173,Novo Mexiletine
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014462 Ultrafiltration The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS).

Related Publications

K M McErlane, and L Igwemezie, and C R Kerr
May 2012, Acta pharmacologica Sinica,
K M McErlane, and L Igwemezie, and C R Kerr
December 1988, Biochemical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
May 1986, British journal of clinical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
January 1989, European journal of clinical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
May 1985, British journal of clinical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
January 1985, Drug metabolism and disposition: the biological fate of chemicals,
K M McErlane, and L Igwemezie, and C R Kerr
December 2004, British journal of clinical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
November 1994, Biochemical pharmacology,
K M McErlane, and L Igwemezie, and C R Kerr
October 2004, Therapeutic drug monitoring,
K M McErlane, and L Igwemezie, and C R Kerr
March 1990, Biochemical pharmacology,
Copied contents to your clipboard!